A Double-blind Trial Comparing the Efficacy, Tolerability and Safety of Monotherapy Topiramate Versus Phenytoin in Subjects With Seizures Indicative of New Onset Epilepsy.

Trial Profile

A Double-blind Trial Comparing the Efficacy, Tolerability and Safety of Monotherapy Topiramate Versus Phenytoin in Subjects With Seizures Indicative of New Onset Epilepsy.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jul 2010

At a glance

  • Drugs Phenytoin; Topiramate
  • Indications Complex partial epilepsy; Tonic-clonic epilepsy
  • Focus Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 14 Jul 2010 Results published in Epilepsia.
    • 05 Dec 2008 Results were presented at the 2008 Annual Meeting of the American Epilepsy Society.
    • 05 Dec 2008 Primary endpoint 'Time to disease recurrence' has not been met, based on information presented at AES 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top